Adaptive Immune Remodeling in Sickle Cell Disease: Linking Hemolysis-Driven Inflammation to Immune Dysfunction

Area of Science:

• Hematology
• Immunology
• Pathophysiology

Background:

• Sickle cell disease (SCD) is recognized as a complex disorder involving immune system dysregulation beyond its definition as a hemoglobinopathy.
• Persistent hemolysis and chronic inflammation are key drivers of immune remodeling in SCD.

Purpose of the Study:

• To propose a mechanistic framework for how hemolysis-induced damage-associated molecular patterns (DAMPs) drive immune alterations in SCD.
• To review current evidence on immune remodeling in pediatric and adult SCD populations.
• To identify potential immunomodulatory and vaccine-focused therapeutic strategies.

Main Methods:

• This is a perspective review integrating existing research from hematopoiesis, inflammation, and adaptive immunity.
• The review synthesizes evidence linking chronic inflammation to specific immune cell alterations and functional deficits.

Main Results:

• Hemolysis-associated DAMPs trigger sustained innate immune activation, altering bone marrow niche, hematopoiesis, and lymphopoiesis.
• Chronic inflammation in SCD is linked to T-cell activation, skewed helper T-cell polarization, impaired germinal center reactions, and B-cell depletion.
• Age-dependent immune remodeling occurs in pediatric and adult SCD patients.

Conclusions:

• Immune dysfunction, driven by hemolysis and inflammation, is central to SCD pathophysiology.
• These immune alterations contribute to increased infection susceptibility, impaired vaccine responses, and alloimmunization.
• Understanding these mechanisms opens avenues for novel immunomodulatory therapies and improved vaccine strategies for SCD.